Amundi’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-925,071
Closed -$18.8M 2055
2022
Q4
$18.8M Buy
925,071
+11,163
+1% +$236K 0.01% 713
2022
Q3
$18.3M Sell
913,908
-148
-0% -$3.04K 0.01% 716
2022
Q2
$17.9M Buy
914,056
+25,832
+3% +$419K 0.01% 649
2022
Q1
$13.8M Sell
888,224
-3,722
-0.4% -$66.9K 0.01% 741
2021
Q4
$19.4M Buy
891,946
+232,260
+35% +$5.45M 0.01% 686
2021
Q3
$15.4M Buy
+659,686
New +$16M 0.01% 744

Other funds holding AHCO

Amundi's AHCO Position: Q1 2023 in Review

Amundi sold out of AdaptHealth (AHCO) in Q1 2023, closing a stake of 925,071 shares — an estimated $18.8M sold.

Amundi first reported a position in AHCO in Q3 2021 and held it in 6 quarters. The position peaked at $19.4M in Q4 2021. 172 funds tracked by Wall St. Rank hold AHCO as of Q1 2023.

  • Amundi reported no remaining AdaptHealth position as of Q1 2023 after selling out during the quarter.
  • Amundi sold 925,071 AdaptHealth shares in Q1 2023, an estimated $18.8M.
  • Amundi first reported a position in AdaptHealth in Q3 2021 and held it in 6 quarters.
  • Amundi's AdaptHealth position peaked at $19.4M in Q4 2021.
  • 172 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2023.

Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.